Request for Covid-19 Impact Assessment of this Report
The United States PVA Foam Embolization Particles market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global PVA Foam Embolization Particles market, reaching US$ million by the year 2028. As for the Europe PVA Foam Embolization Particles landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main PVA Foam Embolization Particles players cover Cook Medical, Sirtex Medical, Merit Medical, and BTG Medical, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of PVA Foam Embolization Particles market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
50μm~350μm
350μm~560μm
560μm~710μm
710μm~1000μm
1000μm~1400μm
1400μm~2000μm
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Uterine Fibroid Embolization
Prostatic Artery Embolization (treatment for Benign Prostatic Hyperplasia or BPH)
Liver Tumor Embolization
Trauma Embolization
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Cook Medical
Sirtex Medical
Merit Medical
BTG Medical
Boston Scientific
Terumo
HENGRUI Medical
INterface BIOmaterials
Alicon
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global PVA Foam Embolization Particles Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for PVA Foam Embolization Particles by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for PVA Foam Embolization Particles by Country/Region, 2017, 2022 & 2028
2.2 PVA Foam Embolization Particles Segment by Type
2.2.1 50μm~350μm
2.2.2 350μm~560μm
2.2.3 560μm~710μm
2.2.4 710μm~1000μm
2.2.5 1000μm~1400μm
2.2.6 1400μm~2000μm
2.3 PVA Foam Embolization Particles Sales by Type
2.3.1 Global PVA Foam Embolization Particles Sales Market Share by Type (2017-2022)
2.3.2 Global PVA Foam Embolization Particles Revenue and Market Share by Type (2017-2022)
2.3.3 Global PVA Foam Embolization Particles Sale Price by Type (2017-2022)
2.4 PVA Foam Embolization Particles Segment by Application
2.4.1 Uterine Fibroid Embolization
2.4.2 Prostatic Artery Embolization (treatment for Benign Prostatic Hyperplasia or BPH)
2.4.3 Liver Tumor Embolization
2.4.4 Trauma Embolization
2.4.5 Others
2.5 PVA Foam Embolization Particles Sales by Application
2.5.1 Global PVA Foam Embolization Particles Sale Market Share by Application (2017-2022)
2.5.2 Global PVA Foam Embolization Particles Revenue and Market Share by Application (2017-2022)
2.5.3 Global PVA Foam Embolization Particles Sale Price by Application (2017-2022)
3 Global PVA Foam Embolization Particles by Company
3.1 Global PVA Foam Embolization Particles Breakdown Data by Company
3.1.1 Global PVA Foam Embolization Particles Annual Sales by Company (2020-2022)
3.1.2 Global PVA Foam Embolization Particles Sales Market Share by Company (2020-2022)
3.2 Global PVA Foam Embolization Particles Annual Revenue by Company (2020-2022)
3.2.1 Global PVA Foam Embolization Particles Revenue by Company (2020-2022)
3.2.2 Global PVA Foam Embolization Particles Revenue Market Share by Company (2020-2022)
3.3 Global PVA Foam Embolization Particles Sale Price by Company
3.4 Key Manufacturers PVA Foam Embolization Particles Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers PVA Foam Embolization Particles Product Location Distribution
3.4.2 Players PVA Foam Embolization Particles Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for PVA Foam Embolization Particles by Geographic Region
4.1 World Historic PVA Foam Embolization Particles Market Size by Geographic Region (2017-2022)
4.1.1 Global PVA Foam Embolization Particles Annual Sales by Geographic Region (2017-2022)
4.1.2 Global PVA Foam Embolization Particles Annual Revenue by Geographic Region
4.2 World Historic PVA Foam Embolization Particles Market Size by Country/Region (2017-2022)
4.2.1 Global PVA Foam Embolization Particles Annual Sales by Country/Region (2017-2022)
4.2.2 Global PVA Foam Embolization Particles Annual Revenue by Country/Region
4.3 Americas PVA Foam Embolization Particles Sales Growth
4.4 APAC PVA Foam Embolization Particles Sales Growth
4.5 Europe PVA Foam Embolization Particles Sales Growth
4.6 Middle East & Africa PVA Foam Embolization Particles Sales Growth
5 Americas
5.1 Americas PVA Foam Embolization Particles Sales by Country
5.1.1 Americas PVA Foam Embolization Particles Sales by Country (2017-2022)
5.1.2 Americas PVA Foam Embolization Particles Revenue by Country (2017-2022)
5.2 Americas PVA Foam Embolization Particles Sales by Type
5.3 Americas PVA Foam Embolization Particles Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC PVA Foam Embolization Particles Sales by Region
6.1.1 APAC PVA Foam Embolization Particles Sales by Region (2017-2022)
6.1.2 APAC PVA Foam Embolization Particles Revenue by Region (2017-2022)
6.2 APAC PVA Foam Embolization Particles Sales by Type
6.3 APAC PVA Foam Embolization Particles Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe PVA Foam Embolization Particles by Country
7.1.1 Europe PVA Foam Embolization Particles Sales by Country (2017-2022)
7.1.2 Europe PVA Foam Embolization Particles Revenue by Country (2017-2022)
7.2 Europe PVA Foam Embolization Particles Sales by Type
7.3 Europe PVA Foam Embolization Particles Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa PVA Foam Embolization Particles by Country
8.1.1 Middle East & Africa PVA Foam Embolization Particles Sales by Country (2017-2022)
8.1.2 Middle East & Africa PVA Foam Embolization Particles Revenue by Country (2017-2022)
8.2 Middle East & Africa PVA Foam Embolization Particles Sales by Type
8.3 Middle East & Africa PVA Foam Embolization Particles Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of PVA Foam Embolization Particles
10.3 Manufacturing Process Analysis of PVA Foam Embolization Particles
10.4 Industry Chain Structure of PVA Foam Embolization Particles
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 PVA Foam Embolization Particles Distributors
11.3 PVA Foam Embolization Particles Customer
12 World Forecast Review for PVA Foam Embolization Particles by Geographic Region
12.1 Global PVA Foam Embolization Particles Market Size Forecast by Region
12.1.1 Global PVA Foam Embolization Particles Forecast by Region (2023-2028)
12.1.2 Global PVA Foam Embolization Particles Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global PVA Foam Embolization Particles Forecast by Type
12.7 Global PVA Foam Embolization Particles Forecast by Application
13 Key Players Analysis
13.1 Cook Medical
13.1.1 Cook Medical Company Information
13.1.2 Cook Medical PVA Foam Embolization Particles Product Offered
13.1.3 Cook Medical PVA Foam Embolization Particles Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Cook Medical Main Business Overview
13.1.5 Cook Medical Latest Developments
13.2 Sirtex Medical
13.2.1 Sirtex Medical Company Information
13.2.2 Sirtex Medical PVA Foam Embolization Particles Product Offered
13.2.3 Sirtex Medical PVA Foam Embolization Particles Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Sirtex Medical Main Business Overview
13.2.5 Sirtex Medical Latest Developments
13.3 Merit Medical
13.3.1 Merit Medical Company Information
13.3.2 Merit Medical PVA Foam Embolization Particles Product Offered
13.3.3 Merit Medical PVA Foam Embolization Particles Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Merit Medical Main Business Overview
13.3.5 Merit Medical Latest Developments
13.4 BTG Medical
13.4.1 BTG Medical Company Information
13.4.2 BTG Medical PVA Foam Embolization Particles Product Offered
13.4.3 BTG Medical PVA Foam Embolization Particles Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 BTG Medical Main Business Overview
13.4.5 BTG Medical Latest Developments
13.5 Boston Scientific
13.5.1 Boston Scientific Company Information
13.5.2 Boston Scientific PVA Foam Embolization Particles Product Offered
13.5.3 Boston Scientific PVA Foam Embolization Particles Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Boston Scientific Main Business Overview
13.5.5 Boston Scientific Latest Developments
13.6 Terumo
13.6.1 Terumo Company Information
13.6.2 Terumo PVA Foam Embolization Particles Product Offered
13.6.3 Terumo PVA Foam Embolization Particles Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Terumo Main Business Overview
13.6.5 Terumo Latest Developments
13.7 HENGRUI Medical
13.7.1 HENGRUI Medical Company Information
13.7.2 HENGRUI Medical PVA Foam Embolization Particles Product Offered
13.7.3 HENGRUI Medical PVA Foam Embolization Particles Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 HENGRUI Medical Main Business Overview
13.7.5 HENGRUI Medical Latest Developments
13.8 INterface BIOmaterials
13.8.1 INterface BIOmaterials Company Information
13.8.2 INterface BIOmaterials PVA Foam Embolization Particles Product Offered
13.8.3 INterface BIOmaterials PVA Foam Embolization Particles Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 INterface BIOmaterials Main Business Overview
13.8.5 INterface BIOmaterials Latest Developments
13.9 Alicon
13.9.1 Alicon Company Information
13.9.2 Alicon PVA Foam Embolization Particles Product Offered
13.9.3 Alicon PVA Foam Embolization Particles Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Alicon Main Business Overview
13.9.5 Alicon Latest Developments
14 Research Findings and Conclusion
Table 1. PVA Foam Embolization Particles Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. PVA Foam Embolization Particles Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of 50μm~350μm
Table 4. Major Players of 350μm~560μm
Table 5. Major Players of 560μm~710μm
Table 6. Major Players of 710μm~1000μm
Table 7. Major Players of 1000μm~1400μm
Table 8. Major Players of 1400μm~2000μm
Table 9. Global PVA Foam Embolization Particles Sales by Type (2017-2022) & (K Units)
Table 10. Global PVA Foam Embolization Particles Sales Market Share by Type (2017-2022)
Table 11. Global PVA Foam Embolization Particles Revenue by Type (2017-2022) & ($ million)
Table 12. Global PVA Foam Embolization Particles Revenue Market Share by Type (2017-2022)
Table 13. Global PVA Foam Embolization Particles Sale Price by Type (2017-2022) & (USD/Unit)
Table 14. Global PVA Foam Embolization Particles Sales by Application (2017-2022) & (K Units)
Table 15. Global PVA Foam Embolization Particles Sales Market Share by Application (2017-2022)
Table 16. Global PVA Foam Embolization Particles Revenue by Application (2017-2022)
Table 17. Global PVA Foam Embolization Particles Revenue Market Share by Application (2017-2022)
Table 18. Global PVA Foam Embolization Particles Sale Price by Application (2017-2022) & (USD/Unit)
Table 19. Global PVA Foam Embolization Particles Sales by Company (2020-2022) & (K Units)
Table 20. Global PVA Foam Embolization Particles Sales Market Share by Company (2020-2022)
Table 21. Global PVA Foam Embolization Particles Revenue by Company (2020-2022) ($ Millions)
Table 22. Global PVA Foam Embolization Particles Revenue Market Share by Company (2020-2022)
Table 23. Global PVA Foam Embolization Particles Sale Price by Company (2020-2022) & (USD/Unit)
Table 24. Key Manufacturers PVA Foam Embolization Particles Producing Area Distribution and Sales Area
Table 25. Players PVA Foam Embolization Particles Products Offered
Table 26. PVA Foam Embolization Particles Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 27. New Products and Potential Entrants
Table 28. Mergers & Acquisitions, Expansion
Table 29. Global PVA Foam Embolization Particles Sales by Geographic Region (2017-2022) & (K Units)
Table 30. Global PVA Foam Embolization Particles Sales Market Share Geographic Region (2017-2022)
Table 31. Global PVA Foam Embolization Particles Revenue by Geographic Region (2017-2022) & ($ millions)
Table 32. Global PVA Foam Embolization Particles Revenue Market Share by Geographic Region (2017-2022)
Table 33. Global PVA Foam Embolization Particles Sales by Country/Region (2017-2022) & (K Units)
Table 34. Global PVA Foam Embolization Particles Sales Market Share by Country/Region (2017-2022)
Table 35. Global PVA Foam Embolization Particles Revenue by Country/Region (2017-2022) & ($ millions)
Table 36. Global PVA Foam Embolization Particles Revenue Market Share by Country/Region (2017-2022)
Table 37. Americas PVA Foam Embolization Particles Sales by Country (2017-2022) & (K Units)
Table 38. Americas PVA Foam Embolization Particles Sales Market Share by Country (2017-2022)
Table 39. Americas PVA Foam Embolization Particles Revenue by Country (2017-2022) & ($ Millions)
Table 40. Americas PVA Foam Embolization Particles Revenue Market Share by Country (2017-2022)
Table 41. Americas PVA Foam Embolization Particles Sales by Type (2017-2022) & (K Units)
Table 42. Americas PVA Foam Embolization Particles Sales Market Share by Type (2017-2022)
Table 43. Americas PVA Foam Embolization Particles Sales by Application (2017-2022) & (K Units)
Table 44. Americas PVA Foam Embolization Particles Sales Market Share by Application (2017-2022)
Table 45. APAC PVA Foam Embolization Particles Sales by Region (2017-2022) & (K Units)
Table 46. APAC PVA Foam Embolization Particles Sales Market Share by Region (2017-2022)
Table 47. APAC PVA Foam Embolization Particles Revenue by Region (2017-2022) & ($ Millions)
Table 48. APAC PVA Foam Embolization Particles Revenue Market Share by Region (2017-2022)
Table 49. APAC PVA Foam Embolization Particles Sales by Type (2017-2022) & (K Units)
Table 50. APAC PVA Foam Embolization Particles Sales Market Share by Type (2017-2022)
Table 51. APAC PVA Foam Embolization Particles Sales by Application (2017-2022) & (K Units)
Table 52. APAC PVA Foam Embolization Particles Sales Market Share by Application (2017-2022)
Table 53. Europe PVA Foam Embolization Particles Sales by Country (2017-2022) & (K Units)
Table 54. Europe PVA Foam Embolization Particles Sales Market Share by Country (2017-2022)
Table 55. Europe PVA Foam Embolization Particles Revenue by Country (2017-2022) & ($ Millions)
Table 56. Europe PVA Foam Embolization Particles Revenue Market Share by Country (2017-2022)
Table 57. Europe PVA Foam Embolization Particles Sales by Type (2017-2022) & (K Units)
Table 58. Europe PVA Foam Embolization Particles Sales Market Share by Type (2017-2022)
Table 59. Europe PVA Foam Embolization Particles Sales by Application (2017-2022) & (K Units)
Table 60. Europe PVA Foam Embolization Particles Sales Market Share by Application (2017-2022)
Table 61. Middle East & Africa PVA Foam Embolization Particles Sales by Country (2017-2022) & (K Units)
Table 62. Middle East & Africa PVA Foam Embolization Particles Sales Market Share by Country (2017-2022)
Table 63. Middle East & Africa PVA Foam Embolization Particles Revenue by Country (2017-2022) & ($ Millions)
Table 64. Middle East & Africa PVA Foam Embolization Particles Revenue Market Share by Country (2017-2022)
Table 65. Middle East & Africa PVA Foam Embolization Particles Sales by Type (2017-2022) & (K Units)
Table 66. Middle East & Africa PVA Foam Embolization Particles Sales Market Share by Type (2017-2022)
Table 67. Middle East & Africa PVA Foam Embolization Particles Sales by Application (2017-2022) & (K Units)
Table 68. Middle East & Africa PVA Foam Embolization Particles Sales Market Share by Application (2017-2022)
Table 69. Key Market Drivers & Growth Opportunities of PVA Foam Embolization Particles
Table 70. Key Market Challenges & Risks of PVA Foam Embolization Particles
Table 71. Key Industry Trends of PVA Foam Embolization Particles
Table 72. PVA Foam Embolization Particles Raw Material
Table 73. Key Suppliers of Raw Materials
Table 74. PVA Foam Embolization Particles Distributors List
Table 75. PVA Foam Embolization Particles Customer List
Table 76. Global PVA Foam Embolization Particles Sales Forecast by Region (2023-2028) & (K Units)
Table 77. Global PVA Foam Embolization Particles Sales Market Forecast by Region
Table 78. Global PVA Foam Embolization Particles Revenue Forecast by Region (2023-2028) & ($ millions)
Table 79. Global PVA Foam Embolization Particles Revenue Market Share Forecast by Region (2023-2028)
Table 80. Americas PVA Foam Embolization Particles Sales Forecast by Country (2023-2028) & (K Units)
Table 81. Americas PVA Foam Embolization Particles Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. APAC PVA Foam Embolization Particles Sales Forecast by Region (2023-2028) & (K Units)
Table 83. APAC PVA Foam Embolization Particles Revenue Forecast by Region (2023-2028) & ($ millions)
Table 84. Europe PVA Foam Embolization Particles Sales Forecast by Country (2023-2028) & (K Units)
Table 85. Europe PVA Foam Embolization Particles Revenue Forecast by Country (2023-2028) & ($ millions)
Table 86. Middle East & Africa PVA Foam Embolization Particles Sales Forecast by Country (2023-2028) & (K Units)
Table 87. Middle East & Africa PVA Foam Embolization Particles Revenue Forecast by Country (2023-2028) & ($ millions)
Table 88. Global PVA Foam Embolization Particles Sales Forecast by Type (2023-2028) & (K Units)
Table 89. Global PVA Foam Embolization Particles Sales Market Share Forecast by Type (2023-2028)
Table 90. Global PVA Foam Embolization Particles Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 91. Global PVA Foam Embolization Particles Revenue Market Share Forecast by Type (2023-2028)
Table 92. Global PVA Foam Embolization Particles Sales Forecast by Application (2023-2028) & (K Units)
Table 93. Global PVA Foam Embolization Particles Sales Market Share Forecast by Application (2023-2028)
Table 94. Global PVA Foam Embolization Particles Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 95. Global PVA Foam Embolization Particles Revenue Market Share Forecast by Application (2023-2028)
Table 96. Cook Medical Basic Information, PVA Foam Embolization Particles Manufacturing Base, Sales Area and Its Competitors
Table 97. Cook Medical PVA Foam Embolization Particles Product Offered
Table 98. Cook Medical PVA Foam Embolization Particles Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 99. Cook Medical Main Business
Table 100. Cook Medical Latest Developments
Table 101. Sirtex Medical Basic Information, PVA Foam Embolization Particles Manufacturing Base, Sales Area and Its Competitors
Table 102. Sirtex Medical PVA Foam Embolization Particles Product Offered
Table 103. Sirtex Medical PVA Foam Embolization Particles Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 104. Sirtex Medical Main Business
Table 105. Sirtex Medical Latest Developments
Table 106. Merit Medical Basic Information, PVA Foam Embolization Particles Manufacturing Base, Sales Area and Its Competitors
Table 107. Merit Medical PVA Foam Embolization Particles Product Offered
Table 108. Merit Medical PVA Foam Embolization Particles Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 109. Merit Medical Main Business
Table 110. Merit Medical Latest Developments
Table 111. BTG Medical Basic Information, PVA Foam Embolization Particles Manufacturing Base, Sales Area and Its Competitors
Table 112. BTG Medical PVA Foam Embolization Particles Product Offered
Table 113. BTG Medical PVA Foam Embolization Particles Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 114. BTG Medical Main Business
Table 115. BTG Medical Latest Developments
Table 116. Boston Scientific Basic Information, PVA Foam Embolization Particles Manufacturing Base, Sales Area and Its Competitors
Table 117. Boston Scientific PVA Foam Embolization Particles Product Offered
Table 118. Boston Scientific PVA Foam Embolization Particles Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 119. Boston Scientific Main Business
Table 120. Boston Scientific Latest Developments
Table 121. Terumo Basic Information, PVA Foam Embolization Particles Manufacturing Base, Sales Area and Its Competitors
Table 122. Terumo PVA Foam Embolization Particles Product Offered
Table 123. Terumo PVA Foam Embolization Particles Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 124. Terumo Main Business
Table 125. Terumo Latest Developments
Table 126. HENGRUI Medical Basic Information, PVA Foam Embolization Particles Manufacturing Base, Sales Area and Its Competitors
Table 127. HENGRUI Medical PVA Foam Embolization Particles Product Offered
Table 128. HENGRUI Medical PVA Foam Embolization Particles Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 129. HENGRUI Medical Main Business
Table 130. HENGRUI Medical Latest Developments
Table 131. INterface BIOmaterials Basic Information, PVA Foam Embolization Particles Manufacturing Base, Sales Area and Its Competitors
Table 132. INterface BIOmaterials PVA Foam Embolization Particles Product Offered
Table 133. INterface BIOmaterials PVA Foam Embolization Particles Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 134. INterface BIOmaterials Main Business
Table 135. INterface BIOmaterials Latest Developments
Table 136. Alicon Basic Information, PVA Foam Embolization Particles Manufacturing Base, Sales Area and Its Competitors
Table 137. Alicon PVA Foam Embolization Particles Product Offered
Table 138. Alicon PVA Foam Embolization Particles Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 139. Alicon Main Business
Table 140. Alicon Latest Developments
List of Figures
Figure 1. Picture of PVA Foam Embolization Particles
Figure 2. PVA Foam Embolization Particles Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global PVA Foam Embolization Particles Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global PVA Foam Embolization Particles Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. PVA Foam Embolization Particles Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of 50μm~350μm
Figure 10. Product Picture of 350μm~560μm
Figure 11. Product Picture of 560μm~710μm
Figure 12. Product Picture of 710μm~1000μm
Figure 13. Product Picture of 1000μm~1400μm
Figure 14. Product Picture of 1400μm~2000μm
Figure 15. Global PVA Foam Embolization Particles Sales Market Share by Type in 2021
Figure 16. Global PVA Foam Embolization Particles Revenue Market Share by Type (2017-2022)
Figure 17. PVA Foam Embolization Particles Consumed in Uterine Fibroid Embolization
Figure 18. Global PVA Foam Embolization Particles Market: Uterine Fibroid Embolization (2017-2022) & (K Units)
Figure 19. PVA Foam Embolization Particles Consumed in Prostatic Artery Embolization (treatment for Benign Prostatic Hyperplasia or BPH)
Figure 20. Global PVA Foam Embolization Particles Market: Prostatic Artery Embolization (treatment for Benign Prostatic Hyperplasia or BPH) (2017-2022) & (K Units)
Figure 21. PVA Foam Embolization Particles Consumed in Liver Tumor Embolization
Figure 22. Global PVA Foam Embolization Particles Market: Liver Tumor Embolization (2017-2022) & (K Units)
Figure 23. PVA Foam Embolization Particles Consumed in Trauma Embolization
Figure 24. Global PVA Foam Embolization Particles Market: Trauma Embolization (2017-2022) & (K Units)
Figure 25. PVA Foam Embolization Particles Consumed in Others
Figure 26. Global PVA Foam Embolization Particles Market: Others (2017-2022) & (K Units)
Figure 27. Global PVA Foam Embolization Particles Sales Market Share by Application (2017-2022)
Figure 28. Global PVA Foam Embolization Particles Revenue Market Share by Application in 2021
Figure 29. PVA Foam Embolization Particles Revenue Market by Company in 2021 ($ Million)
Figure 30. Global PVA Foam Embolization Particles Revenue Market Share by Company in 2021
Figure 31. Global PVA Foam Embolization Particles Sales Market Share by Geographic Region (2017-2022)
Figure 32. Global PVA Foam Embolization Particles Revenue Market Share by Geographic Region in 2021
Figure 33. Global PVA Foam Embolization Particles Sales Market Share by Region (2017-2022)
Figure 34. Global PVA Foam Embolization Particles Revenue Market Share by Country/Region in 2021
Figure 35. Americas PVA Foam Embolization Particles Sales 2017-2022 (K Units)
Figure 36. Americas PVA Foam Embolization Particles Revenue 2017-2022 ($ Millions)
Figure 37. APAC PVA Foam Embolization Particles Sales 2017-2022 (K Units)
Figure 38. APAC PVA Foam Embolization Particles Revenue 2017-2022 ($ Millions)
Figure 39. Europe PVA Foam Embolization Particles Sales 2017-2022 (K Units)
Figure 40. Europe PVA Foam Embolization Particles Revenue 2017-2022 ($ Millions)
Figure 41. Middle East & Africa PVA Foam Embolization Particles Sales 2017-2022 (K Units)
Figure 42. Middle East & Africa PVA Foam Embolization Particles Revenue 2017-2022 ($ Millions)
Figure 43. Americas PVA Foam Embolization Particles Sales Market Share by Country in 2021
Figure 44. Americas PVA Foam Embolization Particles Revenue Market Share by Country in 2021
Figure 45. United States PVA Foam Embolization Particles Revenue Growth 2017-2022 ($ Millions)
Figure 46. Canada PVA Foam Embolization Particles Revenue Growth 2017-2022 ($ Millions)
Figure 47. Mexico PVA Foam Embolization Particles Revenue Growth 2017-2022 ($ Millions)
Figure 48. Brazil PVA Foam Embolization Particles Revenue Growth 2017-2022 ($ Millions)
Figure 49. APAC PVA Foam Embolization Particles Sales Market Share by Region in 2021
Figure 50. APAC PVA Foam Embolization Particles Revenue Market Share by Regions in 2021
Figure 51. China PVA Foam Embolization Particles Revenue Growth 2017-2022 ($ Millions)
Figure 52. Japan PVA Foam Embolization Particles Revenue Growth 2017-2022 ($ Millions)
Figure 53. South Korea PVA Foam Embolization Particles Revenue Growth 2017-2022 ($ Millions)
Figure 54. Southeast Asia PVA Foam Embolization Particles Revenue Growth 2017-2022 ($ Millions)
Figure 55. India PVA Foam Embolization Particles Revenue Growth 2017-2022 ($ Millions)
Figure 56. Australia PVA Foam Embolization Particles Revenue Growth 2017-2022 ($ Millions)
Figure 57. Europe PVA Foam Embolization Particles Sales Market Share by Country in 2021
Figure 58. Europe PVA Foam Embolization Particles Revenue Market Share by Country in 2021
Figure 59. Germany PVA Foam Embolization Particles Revenue Growth 2017-2022 ($ Millions)
Figure 60. France PVA Foam Embolization Particles Revenue Growth 2017-2022 ($ Millions)
Figure 61. UK PVA Foam Embolization Particles Revenue Growth 2017-2022 ($ Millions)
Figure 62. Italy PVA Foam Embolization Particles Revenue Growth 2017-2022 ($ Millions)
Figure 63. Russia PVA Foam Embolization Particles Revenue Growth 2017-2022 ($ Millions)
Figure 64. Middle East & Africa PVA Foam Embolization Particles Sales Market Share by Country in 2021
Figure 65. Middle East & Africa PVA Foam Embolization Particles Revenue Market Share by Country in 2021
Figure 66. Egypt PVA Foam Embolization Particles Revenue Growth 2017-2022 ($ Millions)
Figure 67. South Africa PVA Foam Embolization Particles Revenue Growth 2017-2022 ($ Millions)
Figure 68. Israel PVA Foam Embolization Particles Revenue Growth 2017-2022 ($ Millions)
Figure 69. Turkey PVA Foam Embolization Particles Revenue Growth 2017-2022 ($ Millions)
Figure 70. GCC Country PVA Foam Embolization Particles Revenue Growth 2017-2022 ($ Millions)
Figure 71. Manufacturing Cost Structure Analysis of PVA Foam Embolization Particles in 2021
Figure 72. Manufacturing Process Analysis of PVA Foam Embolization Particles
Figure 73. Industry Chain Structure of PVA Foam Embolization Particles
Figure 74. Channels of Distribution
Figure 75. Distributors Profiles
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...